Radnostix (INIS) EBITDA Margin (2018 - 2026)
Radnostix's EBITDA Margin was -27.22% in Q2 2026, down 26.29 percentage points from -0.92% a year earlier but up 23.22 percentage points from the prior quarter.
Radnostix (INIS) EBITDA Margin (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Radnostix's EBITDA Margin was -22.09% through Jun 30, 2026, down 26.52 percentage points year-over-year; for FY2025, it was -4.24%, down 7.17 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -3.00 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 2.94% in FY2024 (+6.41 pp), -3.47% in FY2023 (+3.94 pp), -7.41% in FY2022 (-6.38 pp) and -1.03% in FY2021 (+0.20 pp).
- Quarterly EBITDA Margin has moved between -50.44% (Q1 2026) and 9.57% (Q4 2024) over five years.
- Compared with a year earlier, EBITDA Margin has declined for four straight quarters, with an average year-over-year change of -10.06 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2021 (a gain of 21.62 percentage points); the worst was Q1 2026 (a drop of 51.45 percentage points).
- Per Business Quant data, INIS's EBITDA Margin in the three quarters before Q2 2026 was -50.44% (Q1 2026), -16.29% (Q4 2025) and -2.46% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 39.16% |
| 10 | Radnostix | 23.81 Mn | 17.92 Mn | 1.36 Mn | -27.35% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27.35% |
| Mar 31, 2026 | -50.58% |
| Dec 31, 2025 | -16.98% |
| Sep 30, 2025 | -2.43% |
| Jun 30, 2025 | -0.89% |
| Mar 31, 2025 | 1.05% |
| Dec 31, 2024 | 9.60% |
| Sep 30, 2024 | 7.17% |
| Jun 30, 2024 | -2.53% |
| Mar 31, 2024 | -5.63% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -7.60% |
| Jun 30, 2023 | -4.47% |
| Mar 31, 2023 | -1.92% |
| Dec 31, 2022 | 2.73% |
| Sep 30, 2022 | -13.91% |
| Jun 30, 2022 | -10.95% |
| Mar 31, 2022 | -9.18% |
| Dec 31, 2021 | -4.82% |
| Sep 30, 2021 | 5.74% |
Radnostix EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INIS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "INIS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INIS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();